Detection of second malignancies during long-term follow-up of testicular cancer survivors
β Scribed by Tomas Buchler; Petra Kubankova; Ludmila Boublikova; Zuzana Donatova; Martin Foldyna; Jana Kanakova; Drahomira Kordikova; Martin Kupec; Jana Nepomucka; Eva Vorsilkova; Jitka Abrahamova
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 215 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Longβterm survivors of testicular cancer (TC) who received cisplatinβbased chemotherapy have an increased risk of cardiovascular disease. A crossβsectional study was performed to objectively assess cardiovascular risk, subclinical atherosclerosis, and endothelial function
Anxiety levels in a sample of 65 long-term cancer survivors were assessed in a study of the effects of a planned discharge from an oncology clinic. Thirty-one percent of patients scored > or = 8, and 12% > or = 11 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS), indicatin
## Abstract ## BACKGROUND The authors investigated the incidence and relative risk of secondary malignant neoplasms in longβterm survivors of osteosarcoma. ## METHODS A comprehensive list of 509 patients with primary osteosarcoma treated at our institution between February 1973 and March 2000 wa
In 1965 we reported mithramycin (plicamycin) to produce objective regression in 7 of 12 patients with advanced testicular carcinoma. Between 1963 and 1975 mithramycin was administered to 62 patients with advanced testicular carcinoma as the initial 1 chemotherapy and to 30 patients who failed 1 to r
## Abstract We investigated the risk of second malignancies among 29,511 survivors of germβcell testicular cancer recorded in 13 cancer registries. Standardized incidence ratios (SIRs) were estimated comparing the observed numbers of second malignancies with the expected numbers obtained from sexβ,